نتائج البحث

High-Throughput Drug Screening in Chondrosarcoma Cells Identifies Effective Antineoplastic Agents Independent of IDH Mutation.

• Authors : Li, Luyuan^1,2 (AUTHOR); Hashemi, Lily³ (AUTHOR); Eid, Josiane^1,2 (AUTHOR)

Subjects: *ISOCITRATE dehydrogenase; *HIGH throughput screening (Drug development); *ANTINEOPLASTIC agents

• Source: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p13003. 17p.

تفاصيل العنوان

Assessment of patient perceptions of counselling on oral antineoplastic agents by a dedicated cancer services pharmacist in an outpatient cancer clinic.

• Authors : McNabb, Lorna¹ (AUTHOR); Metrot, Eva¹ (AUTHOR); Ferrington, Micaela¹ (AUTHOR)

Subjects: *HYPOGLYCEMIC agents; *PATIENTS' attitudes; *ANTINEOPLASTIC agentsWESTERN Australia

• Source: PLoS ONE. 6/13/2024, Vol. 19 Issue 6, p1-12. 12p.

تفاصيل العنوان

Electrochemistry as a Powerful Tool for Investigations of Antineoplastic Agents: A Comprehensive Review.

• Authors : Brycht M; Faculty of Chemistry, Department of Inorganic and Analytical Chemistry, University of Lodz, Lodz, Poland.; Poltorak L

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/analysis ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry ; Electrochemical Techniques*

• Source: Critical reviews in analytical chemistry [Crit Rev Anal Chem] 2024 Aug; Vol. 54 (5), pp. 1017-1108. Date of Electronic Publication: 2022 Aug 15.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9004784 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents—updated MASCC/ESMO consensus recommendation

• Authors : Jordan, Karin; Chan, Alexandre; Gralla, Richard J

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Cancer

• Source: Supportive Care in Cancer. 32(1)

تفاصيل العنوان

Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA) (PARCA)

• Source: Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA)

تفاصيل العنوان

First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

• Source: First-in-Human Study of STX-478, a Mutant-Selective PI3Kα Inhibitor as Monotherapy and in Combination With Other Antineoplastic Agents in

تفاصيل العنوان

Preclinical Safety Assessment of Antineoplastic Agents Based on Live Non-Pathogenic Enteroviruses

• Authors : K. V. Sivak; K. I. Stosman; E. Yu. Kalinina

Subjects: antineoplastic agents; enteroviruses; oncolytic viruses

• Source: Безопасность и риск фармакотерапии, Vol 12, Iss 4, Pp 444-462 (2024)

تفاصيل العنوان

Nuclear Receptors and Stress Response Pathways Associated with the Development of Oral Mucositis Induced by Antineoplastic Agents.

• Authors : Kagaya, Moena¹ (AUTHOR); Uesawa, Yoshihiro¹ (AUTHOR)

• Source: Pharmaceuticals (14248247). Aug2024, Vol. 17 Issue 8, p1086. 15p.

تفاصيل العنوان

LC-MS profiling and cytotoxic activity of Angiopteris helferiana against HepG2 cell line: Molecular insight to investigate anticancer agent.

• Authors : Pandey B; Department of Pharmacy, Madan Bhandari Academy of Health Sciences, Hetauda, Nepal.; Thapa S

Subjects: Molecular Docking Simulation* ; Plant Extracts*/Plant Extracts*/Plant Extracts*/pharmacology ; Plant Extracts*/Plant Extracts*/Plant Extracts*/chemistry

• Source: PloS one [PLoS One] 2024 Dec 31; Vol. 19 (12), pp. e0309797. Date of Electronic Publication: 2024 Dec 31 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Research Progress with Atractylone as an Antitumor Agent.

• Authors : Yao Y; College of Pharmacy, Harbin University of Commerce, Harbin 150076, China.; Heilongjiang Provincial Key Laboratory of Geriatric Medicine, Harbin 150076, China.

Subjects: Sesquiterpenes*/Sesquiterpenes*/Sesquiterpenes*/pharmacology ; Sesquiterpenes*/Sesquiterpenes*/Sesquiterpenes*/chemistry ; Sesquiterpenes*/Sesquiterpenes*/Sesquiterpenes*/therapeutic use

• Source: Molecules (Basel, Switzerland) [Molecules] 2024 Nov 19; Vol. 29 (22). Date of Electronic Publication: 2024 Nov 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان